Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.810
-0.075-1.54%
Volume:8.23M
Turnover:39.48M
Market Cap:30.22B
PE:6.41
High:4.930
Open:4.930
Low:4.755
Close:4.885
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.51
T/O Rate:0.13%
Dividend:0.22
Dividend Rate:4.53%
EPS(LYR):0.751
ROE:8.96%
ROA:2.91%
PB:0.50
PE(LYR):6.41
PS:0.10

Loading ...

China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion for CR Jiangzhong

Reuters
·
Aug 21

KPC Pharmaceuticals Posts H1 2026 Net Loss of RMB 0.36 Billion as Revenue Falls 51%

Bulletin Express
·
Aug 21

CR Sanjiu posts 1.37% H1 2026 revenue growth; net profit slips 7.96%

Bulletin Express
·
Aug 21

China Resources Pharma Reports Interim Results: Subsidiary Net Profit Dips Nearly 8%

Stock News
·
Aug 21

China Resources Pharmaceutical Group - Six-Month Revenue RMB 1.64 Bln, Down 50.97% for Kpc Pharmaceuticals

THOMSON REUTERS
·
Aug 21

CR Pharma Reports 4.91B Yuan Net Profit for Jiangzhong Unit in First Half, Down 5.92%

Stock News
·
Aug 21

China Resources Pharmaceutical - Cr Jiangzhong Proposed to Distribute Cash Dividend of RMB5 for Every 10 Shares

THOMSON REUTERS
·
Aug 21

China Resources Pharmaceutical Group - H1 2026 Revenue Down 2.03% to RMB 4.20 Bln for Tasly Pharmaceutical

THOMSON REUTERS
·
Aug 21

CR Boya Bio-Pharmaceutical, China Resources Pharmaceutical Subsidiary, Posts 77.28% Drop in H1 Net Profit Attributable to Shareholders to RMB 51.19 Million

Reuters
·
Aug 21

China Resources Medical Names Yu Changjiu CFO Effective Aug. 20, 2026

Reuters
·
Aug 20

CHINARES PHARMA Subsidiary Dong-E-E-Jiao Posts 5.66% H1 Net Profit Growth, Revenue Rises 3.39%

Bulletin Express
·
Aug 20

China Resources Pharma Reports 5.66% Net Profit Growth for Subsidiary in H1

Stock News
·
Aug 20

Dong-E-E-Jiao, China Resources Pharma Subsidiary, Posts H1 Net Profit RMB 860.38 Million, up 5.66%

Reuters
·
Aug 20

CHINARES PHARMA Sets 24 Aug 2026 Board Meeting to Approve 1H26 Results and Possible Interim Dividend

Bulletin Express
·
Aug 12

China Resources Pharma to Review Interim Results, Weigh Dividend at Board Meeting

Reuters
·
Aug 12

CHINARES PHARMA Affirms 6.28 Billion Outstanding Shares and Adequate Public Float in July 2026 Return

Bulletin Express
·
Aug 03

China Resources Pharmaceutical Group - Unit to Buy 23.50% of Lier Chemical

THOMSON REUTERS
·
Jul 30

China Resources Pharmaceutical Group - Deal Valued at Rmb5,656.25 Mln or Rmb30.07 Per Share

THOMSON REUTERS
·
Jul 30

China Resources Pharma Unit Sells 1 Billion Yuan Bonds

MT Newswires Live
·
Jul 22

CR Pharma completes RMB 1.00 billion first-tranche medium-term note issue at 1.53% coupon

Bulletin Express
·
Jul 22